Evidence map›Paper›PMID 35260474›Full record

ArticleJournal of medical genetics2023

UK recommendations for

Helen Hanson, Miranda Durkie, Fiona Lalloo, Louise Izatt, Terri P McVeigh, Jackie A Cook, Carole Brewer, James Drummond, Samantha Butler, Treena Cranston and 9 more

Abstract read
In one paragraph

Article in Journal of medical genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Review
  3. Article
  4. To screen or not to screen: complexity ofEndocrine oncology (Bristol, England) · 2026
    Article
  5. Tumor risks and surveillance outcomes inEndocrine oncology (Bristol, England) · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Endocrine oncology (Bristol, England) · 2024
    Article
  10. Co-occurrence ofFrontiers in oncology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Helen HansonSouth West Thames Regional Genetic Services, St George's University Hospitals NHS Foundation Trust, London, UK helen.hanson@stgeorges.nhs.uk.ORCID 0000-0002-3303-8713
Miranda DurkieSheffield Diagnostic Genetics Service, Sheffield Children's NHS Foundation Trust, North East and Yorkshire Genomic Laboratory Hub, Sheffield, UK.
Fiona LallooClinical Genetics Service, Manchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
Louise IzattClinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.ORCID 0000-0003-1258-4843
Terri P McVeighCancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, UK.
Jackie A CookDepartment of Clinical Genetics, Sheffield Children's NHS FoundationTrust, Sheffield, UK.
Carole BrewerDepartment of Clinical Genetics, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
James DrummondEast NHS Genomic Laboratory Hub, Cambridge University Hospitals Genomic Laboratory, Cambridge University Hospital Foundation Trust, Cambridge, UK.
Samantha ButlerMolecular Genetics, West Midlands Regional Genetics Laboratory, Birmingham, West Midlands, UK.
Treena CranstonOxford Molecular Genetics Laboratory, Churchill Hospital, Oxford, UK.
Ruth CaseyDepartment of Endocrinology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Tricia TanSection of Investigative Medicine, Imperial College London, London, UK.
Daniel MorgansteinEndocrinology, Royal Marsden Hospital NHS Trust, London, UK.
Diana M EcclesCancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, UK.ORCID 0000-0002-9935-3169
Marc TischkowitzDepartment of Medical Genetics, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Clare TurnbullDivision of Genetics and Epidemiology, Institute of Cancer Research, London, UK.
Emma Roisin WoodwardClinical Genetics Service, Manchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.ORCID 0000-0002-6297-2855
Eamonn R MaherDepartment of Medical Genetics, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.ORCID 0000-0002-6226-6918
UK Cancer Genetics Centres

Funding

Cancer Research UK 27223Cancer Research UK C61296/A27223Department of Health IS-BRC-1215-20007
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adrenal Gland NeoplasmsParagangliomaPheochromocytomaElectron Transport Complex IIGenetic Predisposition to DiseaseGenetic TestingGerm-Line MutationHumansUnited KingdomElectron Transport Complex IISDHA protein, humanendocrinologygenetic counsellinggenetic predisposition to diseasegenetic testing

Identifiers

PMID35260474
PMCPMC9887350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.